Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia
Hirotoshi Sakaguchi, Yusuke Okuno, Hideki Muramatsu, et al.
Nature Genetics (2013) Vol. 45, Iss. 8, pp. 937-941
Closed Access | Times Cited: 210

Showing 1-25 of 210 citing articles:

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 310-320
Open Access | Times Cited: 1597
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O’Shea, Daniella M. Schwartz, Alejandro V. Villarino, et al.
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 311-328
Open Access | Times Cited: 1327
Genomic and molecular characterization of esophageal squamous cell carcinoma
De‐Chen Lin, Jia‐Jie Hao, Yasunobu Nagata, et al.
Nature Genetics (2014) Vol. 46, Iss. 5, pp. 467-473
Open Access | Times Cited: 585
The landscape of somatic mutations in Down syndrome–related myeloid disorders
Kenichi Yoshida, Tsutomu Toki, Yusuke Okuno, et al.
Nature Genetics (2013) Vol. 45, Iss. 11, pp. 1293-1299
Closed Access | Times Cited: 361
The genomic landscape of nasopharyngeal carcinoma
De‐Chen Lin, Xuan Meng, Masaharu Hazawa, et al.
Nature Genetics (2014) Vol. 46, Iss. 8, pp. 866-871
Closed Access | Times Cited: 336
The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Peter L. Greenberg, Richard M. Stone, Aref Al‐Kali, et al.
Journal of the National Comprehensive Cancer Network (2016) Vol. 15, Iss. 1, pp. 60-87
Open Access | Times Cited: 282
The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz, Amaro Taylor‐Weiner, Tiffany Chang, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1326-1333
Open Access | Times Cited: 263
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases
Éric Solary, Olivier Bernard, Ayalew Tefferi, et al.
Leukemia (2013) Vol. 28, Iss. 3, pp. 485-496
Open Access | Times Cited: 256
Somatic SETBP1 mutations in myeloid malignancies
Hideki Makishima, Kenichi Yoshida, Nhu Nguyen, et al.
Nature Genetics (2013) Vol. 45, Iss. 8, pp. 942-946
Open Access | Times Cited: 248
How I treat juvenile myelomonocytic leukemia
Franco Locatelli, Charlotte M. Niemeyer
Blood (2015) Vol. 125, Iss. 7, pp. 1083-1090
Open Access | Times Cited: 221
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi, et al.
Leukemia (2014) Vol. 28, Iss. 8, pp. 1586-1595
Open Access | Times Cited: 217
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Jane Merlevede, Nathalie Droin, Tingting Qin, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 201
The regulation of JAKs in cytokine signaling and its breakdown in disease
Henrik M. Hammarén, Anniina Virtanen, Juuli Raivola, et al.
Cytokine (2018) Vol. 118, pp. 48-63
Open Access | Times Cited: 186
The genomic landscape of pediatric myelodysplastic syndromes
Jason R. Schwartz, Jing Ma, Tamara Lamprecht, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 171
Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
Aditya Bagrodia, Byron Lee, William Lee, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 33, pp. 4000-4007
Open Access | Times Cited: 170
Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations
Jennifer A. Oberg, Julia L. Glade Bender, Maria Luisa Sulis, et al.
Genome Medicine (2016) Vol. 8, Iss. 1
Open Access | Times Cited: 169
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Michael R. Savona, Luca Malcovati, Rami S. Komrokji, et al.
Blood (2015) Vol. 125, Iss. 12, pp. 1857-1865
Open Access | Times Cited: 172
Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network
Aurélie Caye, Marion Strullu, Fabien Guidez, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1334-1340
Closed Access | Times Cited: 171
JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model
Sandrine Degryse, Charles E. de Bock, Luk Cox, et al.
Blood (2014) Vol. 124, Iss. 20, pp. 3092-3100
Open Access | Times Cited: 141
Juvenile myelomonocytic leukemia: who’s the driver at the wheel?
Charlotte M. Niemeyer, Christian Flotho
Blood (2019) Vol. 133, Iss. 10, pp. 1060-1070
Open Access | Times Cited: 140
Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis
Elisabetta Flex, Mamta Jaiswal, Francesca Pantaleoni, et al.
Human Molecular Genetics (2014) Vol. 23, Iss. 16, pp. 4315-4327
Open Access | Times Cited: 134
RAS diseases in children
Charlotte M. Niemeyer
Haematologica (2014) Vol. 99, Iss. 11, pp. 1653-1662
Open Access | Times Cited: 128
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome
Maurice Labuhn, Kelly Perkins, Sören Matzk, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 123-138.e10
Open Access | Times Cited: 123
Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
Anupriya Agarwal, Ryan J. MacKenzie, Raffaella Pippa, et al.
Clinical Cancer Research (2014) Vol. 20, Iss. 8, pp. 2092-2103
Open Access | Times Cited: 120
Page 1 - Next Page

Scroll to top